SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is seeing massive volatility and high community engagement as traders speculate on a potential short squeeze fueled by its micro-float status and ongoing momentum. While some participants are capitalizing on the aggressive price action and citing sector-wide catalysts, others are issuing warnings regarding the company's financial history and the high risks associated with its trading patterns.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is facing significant bearish pressure as investors grapple with dilution concerns, insider selling, and high cash burn, despite ongoing progress in FAA type certification and upcoming NYC test flight demonstrations. Community sentiment remains deeply divided between long-term bulls highlighting institutional backing from Toyota and Delta, and skeptical shorts who view the stock as overvalued and prone to further technical breakdowns.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as traders debate the impact of its regulatory approval in Singapore and anticipate upcoming quarterly earnings, with the community closely watching for updates on international expansion and product momentum. Sentiment remains divided, as some investors express frustration over price volatility and short-selling pressure, while others maintain a bullish outlook on the company's long-term transformation into a diversified global financial platform.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is currently experiencing significant downward pressure despite a strong earnings report and raised guidance, as investors react to the company's increased capital expenditures and broader cooling sentiment in the AI infrastructure sector. The community is actively debating whether this pullback represents a fundamental break in the growth story or a buying opportunity, with many traders focused on key support levels and the stock's tendency for sharp volatility around earnings events.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is facing significant volatility as investors weigh strong platform metrics and record subscriber growth against concerns over slowing revenue momentum and weaker forward guidance. The community remains divided, with some traders viewing the current sell-off as an attractive entry point into a dominant market leader, while others caution that the stock faces valuation pressure and ongoing churn risks from recent subscription price hikes.

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.

Erasca Inc

Erasca Inc. is facing intense market volatility as investors weigh preliminary trial data against a reported patient death and patent infringement claims from competitor Revolution Medicines. The community remains deeply divided, with some traders debating the company's long-term clinical prospects and the potential for a deeper price decline, while others view the pullback as a significant buying opportunity.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene Corp. is experiencing volatility as investors closely monitor pending legislative votes regarding Affordable Care Act subsidy extensions, which remain a critical catalyst for healthcare plan providers. The community is actively debating the potential impact of this policy uncertainty against Centene's underlying operational resilience and its strategic focus on Medicaid and value-based care.

Rambus, Inc. engages in the provision of cutting-edge semiconductor and Internet Protocol products, spanning memory and interfaces to security, smart sensors and lighting. Its products include Memory Interface Chips, Interface IP, and Security IP. The company was founded by P. Michael Farmwald and Mark A. Horowitz in March 1990 and is headquartered in Sunnyvale, CA.

Rambus Inc.

Rambus is facing intense volatility as market participants react to mixed quarterly guidance, despite strong institutional backing and growth potential in the AI-driven data center sector. The community is actively debating whether the recent sharp pullback represents an attractive long-term entry point or a structural sign that the stocks valuation has become overextended.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing intense community focus as investors speculate on potential hyperscaler partnerships, such as deals with OpenAI or Anthropic, while monitoring upcoming energization milestones at its Sweetwater facility. Traders remain sharply divided, balancing bullish sentiment around the firm's expanding power-capacity pipeline against technical volatility and concerns regarding equity dilution.

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)

Quantum BioPharma Ltd

Quantum BioPharma is trending due to its high-profile $700 million lawsuit against major Canadian banks for alleged stock manipulation, a narrative amplified by recent media exposure and comparisons to other contested equities. While this legal action sparks optimism among some for a potential short squeeze, a strong counter-narrative within the community expresses deep skepticism over the company's operational history, including past dilutions and unfulfilled project milestones.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Axecap Investments LLC Has $3.65 Million Stock Holdings in ACADIA Pharmaceuticals Inc. $ACAD

Axecap Investments LLC decreased its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 32.8% in the 4th quarter, according to its most recent filing with the Securities...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives Consensus Rating of "Moderate Buy" from Brokerages

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twenty analysts that are currently covering the firm, MarketBeat reports...

Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual Meeting

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present multiple original data presentations spanning its portfolio at the 2026 American Academy of Neurology (AAN) Annual...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Short Interest Update

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Get Free Report) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totaling 10,638,508 shares, a...

Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter 2026 financial results on Wednesday, May 6, 2026, after the close of the U.S. financial markets. Acadias...

CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?

CSLLY vs. ACAD: Which Stock Is the Better Value Option?

Will Acadia (ACAD) Beat Estimates Again in Its Next Earnings Report?

Acadia (ACAD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

James Kihara Sells 1,030 Shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Get Free Report) insider James Kihara sold 1,030 shares of the business's stock in a transaction on Tuesday, April 7th. The shares were sold at an average...

ACADIA Pharmaceuticals (NASDAQ:ACAD) EVP Sells $60,139.80 in Stock

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Get Free Report) EVP Mark Schneyer sold 2,709 shares of the firm's stock in a transaction that occurred on Tuesday, April 7th. The stock was sold at an average price of $22.20, for a total value of $60,139.80. Following the completion of the sale, the...

ACADIA Pharmaceuticals (NASDAQ:ACAD) Insider Sells $22,866.00 in Stock

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Get Free Report) insider James Kihara sold 1,030 shares of the business's stock in a transaction that occurred on Tuesday, April 7th. The shares were sold at an average price of $22.20, for a total value of $22,866.00. Following the completion of the sale...

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

ACAD
Acadia Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ACAD News

ACADAcadia Pharmaceuticals Inc